Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anamorelin for Weight Loss and Anorexia in Advanced Pancreatic Cancer
NCT04844970Phase 2Terminated
- Sponsor
- Lahey Hospital & Medical Center
- Start
- Apr 2023
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of anamorelin in cancer cachexia, anorexia nervosa (AN), sponsored by Lahey Hospital & Medical Center. Started Apr 2023; status: terminated.
02
Drugs
anamorelin
03
Conditions
cancer cachexiaanorexia nervosa (AN)
Beyond the preview
Go deeper on NCT04844970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04844970.